Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · IEX Real-Time Price · USD
12.55
-0.01 (-0.08%)
At close: Jul 19, 2024, 4:00 PM
12.90
+0.35 (2.79%)
Pre-market: Jul 22, 2024, 7:22 AM EDT

Cellebrite DI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Revenue
343.46325.11270.65246.25194.91171.85
Revenue Growth (YoY)
22.88%20.12%9.91%26.34%13.42%-
Cost of Revenue
54.0953.2350.7542.5637.8835.82
Gross Profit
289.37271.88219.91203.69157.03136.03
Selling, General & Admin
160.57154.26138.24124.3393.4490.98
Research & Development
86.4584.3980.6265.5454.3846.57
Operating Expenses
247.02238.64218.86189.87147.82137.55
Operating Income
42.3533.241.0413.829.22-1.52
Interest Expense / Income
148.6108.8-119.72-68.48-2.18-2.94
Other Expense / Income
--4.690.9615.138.16
Pretax Income
-106.25-75.56116.0781.34-3.73-6.75
Income Tax
5.615.54-0.0510.915.623.29
Net Income
-111.87-81.1116.1170.43-9.34-10.04
Net Income Growth
--64.85%---
Shares Outstanding (Basic)
197190183144124122
Shares Outstanding (Diluted)
197190195162124122
Shares Change
-0.69%-2.68%20.96%30.59%1.76%-
EPS (Basic)
-0.57-0.430.640.49-0.08-0.08
EPS (Diluted)
-0.57-0.430.590.44-0.08-0.08
EPS Growth
--34.09%---
Free Cash Flow
91.2794.1411.4927.9460.339.92
Free Cash Flow Per Share
0.460.490.060.190.490.08
Gross Margin
84.25%83.63%81.25%82.72%80.57%79.15%
Operating Margin
12.33%10.22%0.39%5.61%4.73%-0.88%
Profit Margin
-32.57%-24.95%42.90%28.60%-4.79%-5.84%
Free Cash Flow Margin
26.58%28.96%4.25%11.35%30.95%5.77%
Effective Tax Rate
---0.04%13.41%--
EBITDA
52.5943.255.5419.87-0.03-5.6
EBITDA Margin
15.31%13.30%2.05%8.07%-0.01%-3.26%
Depreciation & Amortization
10.2410.019.197.015.884.08
EBIT
42.3533.24-3.6512.86-5.91-9.68
EBIT Margin
12.33%10.22%-1.35%5.22%-3.03%-5.63%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).